The multiple roles of computational chemistry in fragment-based drug design

@article{Law2009TheMR,
  title={The multiple roles of computational chemistry in fragment-based drug design},
  author={Richard Law and Oliver Barker and John J. Barker and Thomas Hesterkamp and Robert Godemann and Ole Andersen and Tara Fryatt and Steve Courtney and Dave Hallett and Mark Whittaker},
  journal={Journal of computer-aided molecular design},
  year={2009},
  volume={23 8},
  pages={459-73}
}
Fragment-based drug discovery (FBDD) represents a change in strategy from the screening of molecules with higher molecular weights and physical properties more akin to fully drug-like compounds, to the screening of smaller, less complex molecules. This is because it has been recognised that fragment hit molecules can be efficiently grown and optimised into leads, particularly after the binding mode to the target protein has been first determined by 3D structural elucidation, e.g. by NMR or X… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Fragment-based strategy for structural optimization in combination with 3D-QSAR

Journal of Computer-Aided Molecular Design • 2013
View 7 Excerpts
Highly Influenced

De novo design - hop(p)ing against hope.

Drug discovery today. Technologies • 2013

Novel Strategy for Three-Dimensional Fragment-Based Lead Discovery

Journal of Chemical Information and Modeling • 2011

Similar Papers

Loading similar papers…